TissuPath Publications & Collaborations














  • The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. British Journal of Urology International (2011). Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL. http://www.ncbi.nlm.nih.gov/pubmed/22085203
  • Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours. British Journal Urology International (2011). Corcoran NM, Hovens CM, Hong MK, Pedersen J, Casey RG, Connolly S, Peters J, Harewood L, Gleave ME, Goldenberg SL, Costello AJ – http://www.ncbi.nlm.nih.gov/pubmed/21895937
  • Immunohistochemical study of the cavernous nerves in the periprostatic region. British Journal of Urology International (2011). Costello AJ, Dowdle BW, Namdarian B, Pedersen J, Murphy DG. http://www.ncbi.nlm.nih.gov/pubmed/20942832
  • Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup.Pathology (2011). Hong MK, Namdarian B, Corcoran NM, Pedersen J, Murphy DG, Peters JS, Harewood L, Sapre N, Rzetelski-West K, Costello AJ, Hovens CM – http://www.ncbi.nlm.nih.gov/pubmed/21233675
  • Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers. Urologic Oncology (2011). Namdarian B, Wong E, Galea R, Pedersen J, Chin X, Speirs R, Humbert PO, Costello AJ, Corcoran NM, Hovens CM – – http://www.ncbi.nlm.nih.gov/pubmed/21549621
  • A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance. Journal of Urology (2011). O’Brien BA, Cohen RJ, Ryan A, Sengupta S, Mills J. http://www.ncbi.nlm.nih.gov/pubmed?term=ryan%20mills%20nomogram
  • SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. Journal of Clinical Investigation (2011). Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D, Elsum I, Greenfield A, Tuveson DA, Simon R, Humbert PO – http://www.ncbi.nlm.nih.gov/pubmed/21965329
  • Improved detection of mycobacteria species in formalin-fixed tissue sections. Histopathology (2011). Pedersen JS, Clarke I, Mills J. http://www.ncbi.nlm.nih.gov/pubmed/22092411
  • Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Stem Cells (2011). Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, Meeker AK, Ellem SJ, Risbridger GP, Taylor RA. – http://www.ncbi.nlm.nih.gov/pubmed/21674698


  • Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urologic Oncology (2010). Bruyere F, Namdarian B, Corcoran NM, Pedersen J, Ockrim J, Voelzke BB, Mete U, Costello AJ, Hovens CM – http://www.ncbi.nlm.nih.gov/pubmed/19162513
  • Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case-control study. British Journal of Cancer (2010). Severi G, Shannon BA, Hoang HN, Baglietto L, English DR, Hopper JL, Pedersen J, Southey MC, Sinclair R, Cohen RJ, Giles GG – http://www.ncbi.nlm.nih.gov/pubmed/20606679
  • Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. Journal of Urology (2010). Sherwin JC, Mirmilstein G, Pedersen J, Lawrentschuk N, Bolton D, Mills J – http://www.ncbi.nlm.nih.gov/pubmed/20303103


  • Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer. British Journal of Cancer (2009). Balanathan P, Williams ED, Wang H, Pedersen JS, Horvath LG, Achen MG, Stacker SA, Risbridger GP – http://www.ncbi.nlm.nih.gov/pubmed/19436293
  • Aurora kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint.
  • British Journal of Urology International (2008). Bruyere F, Corcoran NM, Berdjis N, Namdarian B, Pedersen J, Ockrim J, Voelzke BB, Costello AJ, Hovens CM – http://www.ncbi.nlm.nih.gov/pubmed/18341621
  • Early-onset endocrine disruptor-induced prostatitis in the rat. Environmental Health Perspectives (2008). Cowin PA, Foster P, Pedersen J, Hedwards S, McPherson SJ, Risbridger GP – http://www.ncbi.nlm.nih.gov/pubmed/21674698
  • Molecular testing for paraffin embedded material. Pathology (2007). Gonzales M, Susman M, Dale S, Mills J – http://www.ncbi.nlm.nih.gov/pubmed/17886112
  • Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue. Journal of Clinical Neurosciences (2006). Gonzales M, Dale S, Susman M, Mills J. http://www.ncbi.nlm.nih.gov/pubmed/16410204
  • Formation of human prostate tissue from embryonic stem cells. Nat Methods (2006). Taylor RA, Cowin PA, Cunha GR, Pera M, Trounson AO, Pedersen J, Risbridger GP – http://www.ncbi.nlm.nih.gov/pubmed/21674698
  • Local aromatase expression in human prostate is altered in malignancy. J Clin Endocrinol Metab (2004). Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP – http://www.ncbi.nlm.nih.gov/pubmed/15126575
  • Direct response of the murine prostate gland and seminal vesicles to estradiol. Endocrinology (2002). Bianco JJ, Handelsman DJ, Pedersen JS, Risbridger GP. http://www.ncbi.nlm.nih.gov/pubmed/12446620
  • Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev (2002). Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, Husband AJ, Pedersen JS, Frydenberg M, Risbridger GP. http://www.ncbi.nlm.nih.gov/pubmed/12496063
  • Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Molecular Endocrinology (2002). Schmitt JF, Millar DS, Pedersen JS, Clark SL, Venter DJ, Frydenberg M, Molloy PL, Risbridger GP. http://www.ncbi.nlm.nih.gov/pubmed/11818495
  • Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology (2001). McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP. http://www.ncbi.nlm.nih.gov/pubmed/11356695
  • Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J Clin Endocrinol Metab (2000). Mellor SL, Cranfield M, Ries R, Pedersen J, Cancilla B, de Kretser D, Groome NP, Mason AJ, Risbridger GP. http://www.ncbi.nlm.nih.gov/pubmed/11134153

Multi-Factor Authentication (MFA) is the double-lock door for online security that lets you log into your account that has sensitive data of your patients only after passing through two sets of verification processes.

MFA adds an extra layer of security by prompting a second method of authentication alongside the traditional method of signing in with your username and password. This ensures that each login is secure because access will not be granted without your consent.

By asking for an extra verification factor, MFA enhances the security posture of your organization and greatly reduce the odds of data leakages of patient data.

This will close in 0 seconds